Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Part II: the NKG2D-DAP10 signaling complex
- The human NKG2D-DAP10 complex
- Importance of YINM motif in DAP10 signaling
- Coupling to p85 and Grb2/Vav
- Grb2: signaling and activation
- PI3K is required for NKG2D-mediated killing
- CrkL regulates conjugate formation
- Rap1 activation by NKG2D
- JNK1 activation by NKG2D
- Summary of part II
- Part III: inhibitory receptor signaling
- iKIR crosslinking leads SHP1 recruitment
- SHP1 binds directly to the ITIM motif
- iKIR engagement blocks signaling
- Catalytically-inactive SHP1 leads to cell death
- What are the targets of SHP1?
- Vav1 is a target of SHP1
- Summary of part III
- Acknowledgements
Topics Covered
- Regulation of killing by the NKG2D/DAP10 receptor complex
- PI3K pathway regulates cell adhesion and MTOC polarization through a CrkL-Rap1 activation
- Grb2/Vav1 pathway regulates SLP-76 and PLCγ2 activation, calcium signaling and cell-mediated killing
- Inhibitory signaling from killer immunoglobulin receptors that recruit the tyrosine phosphatase SHP1
- SHP1 targets
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Billadeau, D. (2010, October 20). NK cell signaling to cytotoxicity - parts II & III [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/CYLP8916.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Dan Billadeau has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.